Volume 5, Issue 3 (Journal of Research in Dental & Maxillofacial Sciences Summer 2020)                   J Res Dent Maxillofac Sci 2020, 5(3): 7-14 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sezavar M, Shafaei Fard S, Sharifzadeh H, Pahlevan R, Badkoobeh A. Evaluation of the Effect of Platelet-Rich Plasma on Temporomandibular Joint Disorders: A Split-Match Randomized Clinical Trial. J Res Dent Maxillofac Sci. 2020; 5 (3) :7-14
URL: http://jrdms.dentaliau.ac.ir/article-1-280-en.html
1- Assistant Professor, Oral and Maxillofacial surgery Dept, Dental Faculty, Tehran Medical Sciences
2- Post graduate student, Oral and Maxillofacial surgery Dept, Dental Faculty, Tehran Medical Sciences
3- student of dentistry, Dental Faculty, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran , Drrhpn@gmail.com
4- Post graduate student of oral and maxillofacial surgery, Department of Oral and Maxillofacial surgery, School of Dentistry
Abstract:   (916 Views)
Background and Aim: The reduction of temporomandibular joint disorders (TMD) is one of the most significant concerns in dentistry. In contrast to initial treatments, such as pharmacotherapy and physiotherapy, which act as temporary tranquilizers, growth factors have shown promising results in the stimulation of cell division. Given the limited research on the positive impact of platelet-rich plasma (PRP) on the permanent treatment of joint disorders in the knee and the temporomandibular joint (TMJ), we sought to investigate the effect of PRP on TMD.
Materials and Methods: Twenty patients (40 sides) presenting with TMD from 2011-2016 were included in this split-mouth clinical trial. TMD was documented by evaluating pain, limitation in movement, joint sounds, and deviation of the mandible during mouth opening. Next, 0.6 ml of PRP prepared from subjects’ blood was injected into the joints. Patients were followed-up 2, 4, and 6 months postoperatively. The severity of pain was evaluated using Mann-U-Whitney test. The other criteria were analyzed using chi-square test at the follow-up sessions and McNemar's test within each group.
Results: The analysis of the results showed no difference between the two groups at the two-month follow-up. The pain intensity reduced significantly at 4- and 6-month follow-ups (P<0.05). Limitation in movement and joint sounds decreased from the second- to the sixth-month follow-up (P<0.05 and <0.02). The treatment seemed to have no impact on mandibular deviation (P<0.9).
Conclusion: Treatment with PRP seems to be a favorable adjunct in several criteria of TMD.
Full-Text [PDF 270 kb]   (313 Downloads) |   |   Full-Text (HTML)  (192 Views)  

References
1. Pihut M, Szuta M, Ferendiuk E, Zeńczak-Więckiewicz D. Evaluation of pain regression in patients with temporomandibular dysfunction treated by intra-articular platelet-rich plasma injections: a preliminary report. Biomed Res Int. 2014;2014:132369. [DOI:10.1155/2014/132369] [PMID] [PMCID]
2. Bousnaki M, Bakopoulou A, Koidis P. Platelet-rich plasma for the therapeutic management of temporomandibular joint disorders: a systematic review. Int J Oral Maxillofac Surg. 2018 Feb;47(2):188-98. [DOI:10.1016/j.ijom.2017.09.014] [PMID]
3. Kurita Varoli F, Sucena Pita M, Sato S, Issa JP, do Nascimento C, Pedrazzi V. Analgesia evaluation of 2 NSAID drugs as adjuvant in management of chronic temporomandibular disorders. ScientificWorldJournal. 2015;2015:359152. [DOI:10.1155/2015/359152] [PMID] [PMCID]
4. Hancı M, Karamese M, Tosun Z, Aktan TM, Duman S, Savaci N. Intra-articular platelet-rich plasma injection for the treatment of temporomandibular disorders and a comparison with arthrocentesis. J Craniomaxillofac Surg. 2015 Jan;43(1):162-6. [DOI:10.1016/j.jcms.2014.11.002] [PMID]
5. Cömert Kiliç S, Güngörmüş M, Sümbüllü MA. Is Arthrocentesis Plus Platelet-Rich Plasma Superior to Arthrocentesis Alone in the Treatment of Temporomandibular Joint Osteoarthritis? A Randomized Clinical Trial. J Oral Maxillofac Surg. 2015 Aug;73(8):1473-83. [DOI:10.1016/j.joms.2015.02.026] [PMID]
6. Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, et al. International RDC/TMD Consortium Network, International association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache. 2014 Winter;28(1):6-27. [DOI:10.11607/jop.1151] [PMID] [PMCID]
7. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord. 1992;6(4):301-355.
8. Simsek ME. Bilateral platelet rich plasma injections with assisted techniques for temporomandibular joint disorders. Eur Res J. 2016 2:2149-3189. [DOI:10.18621/eurj.2016.2.1.42]
9. Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005 Nov;16(6):1043-54. [DOI:10.1097/01.scs.0000186454.07097.bf] [PMID]
10. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg. 2004 Nov;114(6):1502-8. [DOI:10.1097/01.PRS.0000138251.07040.51] [PMID]
11. Fernández-Ferro M, Fernández-Sanromán J, Blanco-Carrión A, Costas-López A, López-Betancourt A, Arenaz-Bua J, et al. Comparison of intra-articular injection of plasma rich in growth factors versus hyaluronic acid following arthroscopy in the treatment of temporomandibular dysfunction: A randomised prospective study. J Craniomaxillofac Surg. 2017 Apr;45(4):449-54. [DOI:10.1016/j.jcms.2017.01.010] [PMID]
12. Kütük N, Baş B, Soylu E, Gönen ZB, Yilmaz C, Balcioğlu E, et al. Effect of platelet-rich plasma on fibrocartilage, cartilage, and bone repair in temporomandibular joint. J Oral Maxillofac Surg. 2014 Feb;72(2):277-84. [DOI:10.1016/j.joms.2013.09.011] [PMID]
13. Hegab AF, Ali HE, Elmasry M, Khallaf MG. Platelet-Rich Plasma Injection as an Effective Treatment for Temporomandibular Joint Osteoarthritis. J Oral Maxillofac Surg. 2015 Sep;73(9):1706-13. [DOI:10.1016/j.joms.2015.03.045] [PMID]
14. Woodall J Jr, Tucci M, Mishra A, Asfour A, Benghuzzi H. Cellular effects of platelet rich plasmainterleukin1 release from prp treated macrophages. Biomed Sci Instrum. 2008;44:489-94.
15. Civinini R, Macera A, Nistri L, Redl B, Innocenti M. The use of autologous blood-derived growth factors in bone regeneration. Clin Cases Miner Bone Metab. 2011 Jan-Apr;8(1):25-31.
16. Anitua E, Sánchez M, Nurden AT, Zalduendo MM, de la Fuente M, Azofra J, et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford). 2007 Dec;46(12):1769-72. [DOI:10.1093/rheumatology/kem234] [PMID]
17. Zotti F, Albanese M, Rodella LF, Nocini PF. Platelet-Rich Plasma in Treatment of Temporomandibular Joint Dysfunctions: Narrative Review. Int J Mol Sci. 2019 Jan 11;20(2):277. [DOI:10.3390/ijms20020277] [PMID] [PMCID]
18. van Buul GM, Koevoet WL, Kops N, Bos PK, Verhaar JA, Weinans H, et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports Med. 2011 Nov;39(11):2362-70. [DOI:10.1177/0363546511419278] [PMID]
19. Lippross S, Moeller B, Haas H, Tohidnezhad M, Steubesand N, Wruck CJ, et al. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint. Arthritis Rheum. 2011 Nov;63(11):3344-53. [DOI:10.1002/art.30547] [PMID]
20. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009 Mar;27(3):158-67. [DOI:10.1016/j.tibtech.2008.11.009] [PMID]
21. Azizi A, Dabirmoghadam P, Keykha F. Comparison of the Concentration of Salivary IL-8 in Patients with Oral Squamous Cell Carcinoma and Healthy Subjects . J Res Dentomaxillofac Sci. 2016; 1 (3) :28-32. [DOI:10.18869/acadpub.jrdms.1.3.28]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2021 CC BY-NC 4.0 | Journal of Research in Dental and Maxillofacial Sciences

Designed & Developed by : Yektaweb